https://orcid.org/0000-0002-2240-5768
References
- Samet JH, Botticelli M, Bharel M. Methadone in primary care – one small step for Congress, one giant leap for addiction treatment. N Engl J Med. 2018;379(1):7–8.
- Fiscella K, Wakeman SE, Beletsky L. Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: X the X waiver. JAMA Psychiatry. 2019;76(3):229–230.
- GovTrack. Summary of H.R. 2482: Mainstreaming Addiction Treatment Act of 2019. GovTrack.us; 2020. https://www.govtrack.us/congress/bills/116/hr2482/summary. Accessed February 7, 2020.
- Davis CS, Carr DH. Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States. Int J Drug Policy. 2019;73:42–48.
- Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs, Board on Population Health and Public Health Practice, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Opportunities to improve opioid use disorder and infectious disease services: integrating responses to a dual epidemic. Washington, D.C.: National Academies Press; 2020.
- MARA International.™ Medication-Assisted Recovery Anonymous; 2020. https://www.mara-international.org/. Accessed March 26, 2020.
- Pouget ER, Sandoval M, Nikolopoulos GK, Friedman SR. 2015. Immediate impact of Hurricane Sandy on people who inject drugs in New York City. Subst Use Misuse. 2015; 50(7):878–884.
- McClure B, Mendoza S, Duncan L, Rotrosen J, Hansen H. Effects of regulation on methadone and buprenorphine provision in the wake of Hurricane Sandy. J Urban Health. 2014;91(5):999–1008.
- Rutkow L, Vernick JS, Mojtabai R, Rodman SO, Kaufmann CN. Legal challenges for substance abuse treatment during disasters. PS. 2012;63(1):1–9.
- Elflein J, Number of pharmacists in the U.S. from 2001 to 2016. Statista; 2018. https://www.statista.com/statistics/185723/number-of-pharmacists-in-the-us-since-2001/. Accessed March 22, 2020.
- Green TC, Soipe A, Baloy B, et al. Pharmacy on-site overdose protocols and prevention of overdose. Sub Abuse. 2020;11:1–5.
- American Pharmacists Association. Increasing access to and advocacy for medications for opioid use disorder; 2020. https://www.pharmacist.com/sites/default/files/audience/NBI%20%2308%20-%20Medications%20for%20Opioid%20Use%20Disorder%20. (MOUD)-FINAL_0.pdf. Accessed March 26, 2020.
- Substance Abuse and Mental Health Services Administration. FAQs: Provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency; 2020. https://www.samhsa.gov/sites/default/files/faqs-for-oud-prescribing-and-dispensing.pdf. Accessed March 22, 2020.
- Compton WM, Jones CM, Stein JB, Wargo EM. Promising roles for pharmacists in addressing the US opioid crisis. Res Social Adm Pharm. 2019;15(8):910–916.
- Calcaterra SL, Bach P, Chadi A, et al. Methadone matters: what the United States can learn from the global effort to treat opioid addiction. J Gen Intern Med. 2019;34(6):1039–1042.
- Strang J, Hall W, Hickman M, Bird SM. Impact of supervision of methadone consumption on deaths related to methadone overdose (1993–2008): analyses using OD4 index in England and Scotland. BMJ. 2010;341(2):c4851–c4851.
- Levander XA, Wakeman SE. Covid-19 will worsen the opioid overdose crisis is we don’t prepare now. STAT; 2020. https://www.statnews.com/2020/03/17/covid-19-will-worsen-the-opioid-overdose-crisis-if-we-dont-prepare-now/. Accessed March 26, 2020.
- Frank JW, Wakeman SE, Gordon AJ. No end to the crisis without an end to the waiver. Sub Abuse. 2018;39(3):263–265.
- Tierney M, Finnell DS, Naegle MA, LaBelle C, Gordon AJ. Advanced practice nurses: increasing access to opioid treatment by expanding the pool of qualified buprenorphine prescribers. Sub Abuse. 2015;36(4):389–392.
- Naegle M, Mitchell AM, Flinter M, Dunphy L, Vanhook P, Delaney KR. Opioid misuse epidemic: addressing opioid prescribing and organization initiatives for holistic, safe and compassionate care. Nurs Outlook. 2017;65(4):477–479.
- Barnett ML, Lee D, Frank RG. In Rural Areas, Buprenorphine waiver adoption since 2017 driven by nurse practitioners and physician assistants. Health Aff. 2019;38(12):2048–2056.
- Walsh SL, Long KQ. Deploying science to change hearts and minds: Responding to the opioid crisis. Prev Med. 2019;128:105780.